Elevated relative mortality risk with mild-to-moderate chronic kidney disease decreases with age

被引:85
作者
Raymond, Neil T.
Zehnder, Daniel
Smith, Stephen C. H.
Stinson, Julie A.
Lehnert, Hendrik
Higgins, Robert M.
机构
[1] Univ Hosp Coventry & Warwickshire NHS Trust, Dept Nephrol, Coventry CV2 2DX, W Midlands, England
[2] Univ Warwick, Warwick Med Sch, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England
[3] Univ Warwick, Warwick Med Sch, Clin Sci Res Inst, Coventry CV4 7AL, W Midlands, England
关键词
all-cause mortality; chronic kidney disease; diabetes; South Asian ethnicity;
D O I
10.1093/ndt/gfm396
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Renal disease is common in the general population and whilst few people progress to end-stage renal failure, mortality is increased. The aim of this study was to examine all-cause mortality risk in relation to chronic kidney disease (CKD) stages defined by estimated glomerular filtration rate (eGFR). Methods. Data were extracted from a computerized central laboratory system for a defined geographical area over a 3-year study period. The eGFR was calculated using the four-variable Modification of Diet in Renal Disease (MDRD) formula and aligned to the MDRD laboratory. Average annual mortality and relative risk (RR) of all-cause mortality was determined and compared for defined age and CKD bands. Results. 106366 participants (55.5 female; 85 White, 13 South Asian, 2 Black and others) were eligible and studied, representing 49 of the Coventry adult population. 12540 (12) of the sample had some evidence of decreased kidney function, with an eGFR 60ml/min/1.73m(2). 7611 (7) participants died and there were significantly elevated risks of mortality with increasing renal dysfunction; RR 4.0, 8.3, 16.2 and 43.5 for eGFR 4559, 3044, 1529 and 15ml/min/1.73m(2), respectively. Within age bands, RRs were statistically significantly raised with CKD progression and within CKD stage, RR of death decreased as age increased. Conclusions. CKD prevalence increased with age and absolute and RR of mortality increased with progression of CKD. People aged over 75 years, with mild-to-moderate renal disease, representing 41 of this age group, have no increased RR of mortality. Further study of CKD and mortality, particularly progression over time and with respect to age is needed.
引用
收藏
页码:3214 / 3220
页数:7
相关论文
共 35 条
[1]  
[Anonymous], 2002, Am J Kidney Dis
[2]  
*BRADF HLTH AUTH C, S AS NAM AN 1996 VER
[3]   Prevalence of kidney damage in Australian adults: The AusDiab Kidney Study [J].
Chadban, SJ ;
Briganti, EM ;
Kerr, PG ;
Dunstan, DW ;
Welborn, TA ;
Zimmet, PZ ;
Atkins, RC .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (07) :S131-S138
[4]  
CLARK TJ, 1993, NEPHROL DIAL TRANSPL, V8, P146
[5]   Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III) [J].
Clase, CM ;
Garg, AX ;
Kiberd, BA .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (05) :1338-1349
[6]   Chronic kidney disease and cardiovascular disease in the Medicare population [J].
Collins, AJ ;
Li, SL ;
Gilbertson, DT ;
Liu, JN ;
Chen, SC ;
Herzog, CA .
KIDNEY INTERNATIONAL, 2003, 64 :S24-S31
[7]   Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate [J].
Coresh, J ;
Astor, BC ;
McQuillan, G ;
Kusek, J ;
Greene, T ;
Van Lente, F ;
Levey, AS .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (05) :920-929
[8]   Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey [J].
Coresh, J ;
Astor, BC ;
Greene, T ;
Eknoyan, G ;
Levey, AS .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (01) :1-12
[9]  
*COV CIT COUNC, 2001, 2001 CENS STAT
[10]   Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency [J].
Culleton, BF ;
Larson, MG ;
Wilson, PWF ;
Evans, JC ;
Parfrey, PS ;
Levy, D .
KIDNEY INTERNATIONAL, 1999, 56 (06) :2214-2219